BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35256068)

  • 1. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):14-21. PubMed ID: 35256068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia.
    García-Álvarez L; Martínez-Cao C; Bobes-Bascarán T; Portilla A; Courtet P; de la Fuente-Tomás L; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2020 Jun; ():. PubMed ID: 32517967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
    Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(1):22-28. PubMed ID: 35256069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia.
    Martínez-Cao C; García-Álvarez L; Bobes-Bascarán T; de la Fuente-Tomás L; Fernández-Egea E; Velasco Á; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Sáiz-Martínez PA; García-Portilla MP; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2020 Jun; ():. PubMed ID: 32507728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spanish Validation of the MAP-SR: Two Heads Better Than One for the Assessment of Negative Symptoms of Schizophrenia.
    García-Portilla MP; García-Álvarez L; de la Fuente-Tomás L; Dal Santo F; Velasco A; González-Blanco L; Zurrón-Madera P; Fonseca-Pedrero E; Bobes-Bascarán MT; Sáiz PA; Bobes J
    Psicothema; 2021 Aug; 33(3):473-480. PubMed ID: 34297678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spanish validation of the Negative Symptom Assessment-16 (NSA-16) in patients with schizophrenia.
    Garcia-Alvarez L; Garcia-Portilla MP; Saiz PA; Fonseca-Pedrero E; Bobes-Bascaran MT; Gomar J; Muñiz J; Bobes J
    Rev Psiquiatr Salud Ment (Engl Ed); 2018; 11(3):169-175. PubMed ID: 29628403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the French version of the self-evaluation of negative symptoms (SNS)].
    Hervochon C; Bourgeois V; Rotharmel M; Duboc JB; Le Goff B; Quesada P; Campion D; Dollfus S; Guillin O
    Encephale; 2018 Dec; 44(6):512-516. PubMed ID: 29195803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polish version of the Self-evaluation of Negative Symptoms (SNS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Szpalik R; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):551-559. PubMed ID: 31522196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing negative symptoms in schizophrenia: Validity of the clinical assessment interview for negative symptoms in Singapore.
    Rekhi G; Ang MS; Yuen CKY; Ng WY; Lee J
    Schizophr Res; 2019 Apr; 206():177-182. PubMed ID: 30558979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Turkish version of the self-evaluation of negative symptoms scale (SNS).
    Polat I; Ince Guliyev E; Elmas S; Karakaş S; Aydemir Ö; Üçok A
    Int J Psychiatry Clin Pract; 2022 Sep; 26(3):221-227. PubMed ID: 35700173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the lithuanian version of the self-evaluation of negative symptoms scale (SNS).
    Montvidas J; Adomaitienė V; Leskauskas D; Dollfus S
    Nord J Psychiatry; 2021 Jul; 75(5):351-355. PubMed ID: 33356749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.
    Dollfus S; Mach C; Morello R
    Schizophr Bull; 2016 May; 42(3):571-8. PubMed ID: 26564898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Arabic version of the "self-evaluation of negative symptoms" scale (SNS).
    Hajj A; Hallit S; Chamoun K; Sacre H; Obeid S; Haddad C; Dollfus S; Rabbaa Khabbaz L
    BMC Psychiatry; 2020 May; 20(1):240. PubMed ID: 32408876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motivation and Pleasure Scale-Self-Report (MAP-SR): Validation of the German version of a self-report measure for screening negative symptoms in schizophrenia.
    Engel M; Lincoln TM
    Compr Psychiatry; 2016 Feb; 65():110-5. PubMed ID: 26773998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
    Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
    Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
    Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
    Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
    Goldring A; Borne S; Hefner A; Thanju A; Khan A; Lindenmayer JP
    Schizophr Res; 2020 Oct; 224():159-166. PubMed ID: 33071071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and Reliability Study of Turkish Version of Clinical Assessment Interview for Negative Symptoms (CAINS).
    Vayisoğlu S; Karahan S; Gürel ŞC; Yağcioğlu AEA
    Noro Psikiyatr Ars; 2024; 61(1):59-65. PubMed ID: 38496217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms.
    Llerena K; Park SG; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
    Compr Psychiatry; 2013 Jul; 54(5):568-74. PubMed ID: 23351831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.